As a rare subtype of osteosarcoma, TOS was firstly described by Paget (
2), and Gaylord (
9) thought that these lesions were malignant aneurysms of the bone in 1903. However, it was Ewing who was the first to consider TOS as a variant of osteogenic sarcoma (
2). In 1976, Matsuno et al. (
10) reported 25 cases of TOS and proposed the standard for diagnosis. TOS is characterized by multiple, aneurysmally-dilated, blood-filled cavities with high-grade sarcomatous cells at the peripheral rim and within the septa (
1-
4). Similar to conventional osteosarcoma, TOS has the same distribution in race, clinical symptoms and location in the bone (
3). ABCs are benign intraosseous solitary tumors consisting of large thin-walled cavities, which are filled with blood when examined macroscopically (
11,
12). ABCs are rare bony tumors constituting only 1% - 2% of all bone tumors (
12,
13). ABCs were considered initially to be pseudotumors, but identification of fusion genes indicated that primary ABCs are true bone neoplasms (
14). Even though the clinical, pathological and imaging characteristics of TOS have been sufficiently described in the literature (
1,
2,
8), reaching a correct diagnosis remains challenging, and malignant TOS can be readily misdiagnosed as benign ABC.
In our study, TOS was more prevalent in males than in females (10:17 or 58.8%) with a mean onset age of 25.4 years consistent with the literature, with the percentage of male prevalence of 54% - 67% in previous studies (
1,
2,
4) and 58.8% in our study. Pathological fracture occurred in three of seventeen patients (17.6%) in our study but was reported as 33% in the literature (
4), which is much higher than that for conventional osteosarcoma (6% - 13%) (
15,
16). This high incidence of pathological fracture may be caused by massive bone destruction in TOS (
4). TOS mainly occurs at the metaphyses of long tubular bones, especially in the lower extremities. The alkaline phosphatase was mostly normal, which is quite different from conventional osteosarcoma, probably due to inactivity of pathological ossification in the tumor. ABC has a higher incidence than TOS and can be divided into primary and secondary subtypes. The age is younger for ABC than for TOS, and ABC is more prevalent in females than in males. Various theories have been suggested for the origin of ABC including arteriovenous shunts, traumatic bleeding and bleeding from a prior bony lesion; however, the pathogenesis remains to be determined (
17-
19). Trauma is a frequent inducement factor probably leading to venous occlusion or arteriovenous shunts to change the local hemodynamic status.
In imaging, TOS is characterized by bone destruction with malignant features including periosteal reaction, Codman triangle, soft tissue masses, ill-defined margins, wide transitional band, pathological fracture, and tumor ossification/calcification, which indicate malignancy of tumors. ABCs are locally destructive and expansile cystic lesions with coarse bony septa, narrow transitional band and sclerotic rim, which are characteristics of benign tumors. Multiple cysts and fluid-fluid levels can both be seen in these two diseases. However, in TOS, the fluid-fluid levels had hypointense signal in the upper level and isointense signal in the lower level in T1WI, but hyperintense and isointense signal (5/12) in the lower level in T2 WI. The fluid-fluid levels indicate bleeding inside the lesion and are non-specific signs (
7). CT or MRI enhancement in TOS showed thick cystic wall, septa and strong nodular enhancement. In ABC, the enhancement is not as strong as in TOS. In ABC, the complete or incomplete low signal rim in all lesions in MRI may be a fibrous membrane envelope, sclerotic rim or bone shell, with a higher incidence than in TOS, which is an imaging feature different from TOS. The features helpful for differentiation of TOS from ABC are periosteal reaction, soft tissue masses, wide transitional band and high incidences of ill-defined borders, and a sclerotic rim has a higher incidence in ABC than in TOS. The long tubular bones in limbs do not overlap, and plain films and CT have the same diagnostic effect in evaluating bone destruction, edges of destruction and periosteal reaction in long tubular bones. However, CT can better show details of bone destruction, soft tissue masses and lesion edges. MRI is better in demonstrating lesion range and fluid-fluid levels. Combination of the three imaging modalities helps making a correct diagnosis.
TOS and ABC have similar pathological features of multiple cysts filled with blood, septa and colored band in low power microscopy. In high power microscopy, the blood cyst septa and interval in TOS had tumor cells of high anaplasia, polymorphy and atypia with pathological mitotic imaging; whereas, the cells in the cystic septa had neither cellular atypia nor pathological mitotic imaging. In one case with TOS, radiating tumor bone occurred similar to conventional osteosarcoma, which is very rare and should be combined with clinical, imaging and pathological data for correct diagnosis. Aspiration biopsy should not be performed for pathological examination because the possibility to obtain malignant septa tumor cells is very low, and open biopsy should be performed especially when aspiration biopsy cannot make a correct diagnosis.
In conclusion, clinical, imaging and pathological characteristics should be combined to make a correct differential diagnosis between telangiectatic osteosarcoma and aneurysmal bone cyst.